Advocacy Alert: June 2022 Advocacy Update for BHAP Members
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: June 2022 Advocacy Update for BHAP Members June 15, 2022 Greetings, BHAP Members! On behalf of Slingshot Solutions, thank you for your membership in BHAP and your...
Advocacy Alert: CDC’s Draft Clinical Practice Guideline for Prescribing Opioids Open for Public Comment
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: CDC’s Draft Clinical Practice Guideline for Prescribing Opioids Open for Public Comment February 17, 2022 via SAMHSA (Substance Abuse and Mental Health...
Advocacy Alert: Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay January 20, 2022 via SAMHSA On January 13, 2022, Miriam...
Advocacy Alert: January 2022 Advocacy Update for BHAP Members
Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: January 2022 Advocacy Update for BHAP Members January 14, 2022 Greetings, BHAP Members! On behalf of Slingshot Solutions, thank you for your membership in BHAP...
A national membership association that provides education and advocacy for those in the behavioral health and addiction treatment industries.
We are the leading and unifying voice of addiction-focused treatment programs.
